BACKGROUND: UNAIDS models use data from the International epidemiology Databases to Evaluate AIDS (IeDEA) collaboration in setting assumptions about mortality rates after antiretroviral treatment (ART) initiation. This study aims to update these assumptions with new data, to quantify the extent of regional variation in ART mortality and to assess trends in ART mortality. METHODS: Adult ART patients from Africa, Asia and the Americas were included if they had a known date of ART initiation during 2001-2017 and a baseline CD4 cell count. In cohorts that relied only on passive follow-up (no patient tracing or linkage to vital registration systems), mortality outcomes were imputed in patients lost to follow-up based on a meta-analysis of tracin...
INTRODUCTION The Joint United Nations Programme on HIV/AIDS (UNAIDS) projections of paediatric HI...
OBJECTIVE: To provide a broad and up-to-date picture of the effect of antiretroviral therapy (ART) p...
Objective: To estimate mortality in HIV-positive patients starting combination antiretroviral therap...
Background: UNAIDS models use data from the International epidemiology Databases to Evaluate AIDS (I...
BACKGROUND UNAIDS models use data from the International epidemiology Databases to Evaluate AIDS ...
BACKGROUND Women account for over half of persons living with HIV/AIDS globally. We examined geog...
Background: The rollout of antiretroviral therapy (ART) is one of the largest public health interven...
BACKGROUND: The rollout of antiretroviral therapy (ART) is one of the largest public health interven...
Background:The rollout of antiretroviral therapy (ART) is one of the largest public health intervent...
BACKGROUND: Substantial falls in the mortality of people living with HIV (PLWH) have been observed s...
Background: Substantial falls in the mortality of people living with HIV (PLWH) have been observed s...
Background: Mortality in HIV-infected patients has declined substantially with combination antiretro...
OBJECTIVE To estimate mortality in HIV-positive patients starting combination antiretroviral ther...
In resource-limited countries, estimating CD4-specific incidence rates of mortality and morbidity am...
BACKGROUND: High early mortality in patients with HIV-1 starting antiretroviral therapy (ART) in sub...
INTRODUCTION The Joint United Nations Programme on HIV/AIDS (UNAIDS) projections of paediatric HI...
OBJECTIVE: To provide a broad and up-to-date picture of the effect of antiretroviral therapy (ART) p...
Objective: To estimate mortality in HIV-positive patients starting combination antiretroviral therap...
Background: UNAIDS models use data from the International epidemiology Databases to Evaluate AIDS (I...
BACKGROUND UNAIDS models use data from the International epidemiology Databases to Evaluate AIDS ...
BACKGROUND Women account for over half of persons living with HIV/AIDS globally. We examined geog...
Background: The rollout of antiretroviral therapy (ART) is one of the largest public health interven...
BACKGROUND: The rollout of antiretroviral therapy (ART) is one of the largest public health interven...
Background:The rollout of antiretroviral therapy (ART) is one of the largest public health intervent...
BACKGROUND: Substantial falls in the mortality of people living with HIV (PLWH) have been observed s...
Background: Substantial falls in the mortality of people living with HIV (PLWH) have been observed s...
Background: Mortality in HIV-infected patients has declined substantially with combination antiretro...
OBJECTIVE To estimate mortality in HIV-positive patients starting combination antiretroviral ther...
In resource-limited countries, estimating CD4-specific incidence rates of mortality and morbidity am...
BACKGROUND: High early mortality in patients with HIV-1 starting antiretroviral therapy (ART) in sub...
INTRODUCTION The Joint United Nations Programme on HIV/AIDS (UNAIDS) projections of paediatric HI...
OBJECTIVE: To provide a broad and up-to-date picture of the effect of antiretroviral therapy (ART) p...
Objective: To estimate mortality in HIV-positive patients starting combination antiretroviral therap...